Improved therapeutic control of heterodimeric and single chain forms of interleukin-12

作者: Charles C. Reed , Chi Zhang , Gregory Ian Frost , Joan Mazzarelli Sopczynski

DOI:

关键词: BiochemistryGenetically modified organismInterleukin 12ChemistryMoleculeMembrane boundIn vivoLigand (biochemistry)Peptide sequenceSingle chain

摘要: The present invention relates to modified forms of IL-12. These IL-12 may be engineered have a shortened in vivo half-life compared and/or enhanced localization biological effects that corresponding non-modified form IL- 12. Short and membrane bound provide greater therapeutic control for delivery, particular when used combination with ligand inducible delivery Modified include heterodimeric p35/p40, single chain wherein naturally occurring amino acid sequence is genetically enhance susceptibility the molecule proteolytic degradation.

参考文章(7)
Young Chul Sung, Sung Hee Lee, Sang Jun Ha, Jun Chang, Man Ki Song, Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant ,(2001)
Deepa Deshpande, Jeff Nordstrom, Bruce Freimark, Il-12 gene expression and delivery systems and uses ,(1997)
Wen-Yu Pan, Chia-Hui Lo, Chun-Chi Chen, Ping-Yi Wu, Steve R Roffler, Song-Kun Shyue, Mi-Hua Tao, Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains. Molecular Therapy. ,vol. 20, pp. 927- 937 ,(2012) , 10.1038/MT.2012.10
Stephen James Russell, Farzin Farzaneh, Johannes Adrianus Gäken, Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases ,(1999)
Joan Mazzarelli Sopczynski, Chi Zhang, Single chain il-12 nucleic acids, polypeptids, and uses thereof ,(2014)